LIGAND PHARMACEUTICALS INCORPORATED Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 108.66 thousand shares for the 6-month period ending 2012-06-30, per its 10-Q/A filed 2012-11-14.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2012-11-14
- 2012-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month 108.66K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month |
|---|---|
| 2012-06-30 | 108.66K shares 10-Q/A · filed 2012-11-14 |